Functional Characterization Experiment summary for ENCSR176UAM
doi:10.17989/ENCSR176UAM
Summary
- Status
- released
- Assay
- STARR-seq
- Biosample summary
- Homo sapiens A549 genetically modified (episome) using transient transfection treated with 1 μM CpdA (antagonist) for 4 hours
- Biosample Type
- cell line
- Replication type
- isogenic
- Treatments
- 1 μM CpdA for 4 hours
- Nucleic acid type
- RNA
- Library starting quantity
- 75µg
- Size range
- 900-1000
- Extraction method
- Qiagen RNA extraction
- Strand specificity
- Strand-specific (reverse)
- Platform
- Illumina NovaSeq 6000
- Controls
Attribution
ENCODE4 project
- Lab
- Tim Reddy, Duke
- Award
- UM1HG009428 (Tim Reddy, Duke)
- Project
- ENCODE
- Aliases
- tim-reddy:A549-wg-starrseq-CpdA
- Date submitted
- June 11, 2021
- Date released
- June 17, 2021
Isogenic replicates
Isogenic replicate | Technical replicate | Summary | Biosample | Modifications | Library |
---|---|---|---|---|---|
2 | 1 | Homo sapiens A549 cell line genetically modified (episome) using transient transfection treated with 1 μM CpdA (antagonist) for 4 hours | ENCBS371JSE | ENCGM016JFT | ENCLB955TTJ |
2 | 3 | Homo sapiens A549 cell line genetically modified (episome) using transient transfection treated with 1 μM CpdA (antagonist) for 4 hours | ENCBS371JSE | ENCGM016JFT | ENCLB688YPK |
1 | 4 | Homo sapiens A549 cell line genetically modified (episome) using transient transfection treated with 1 μM CpdA (antagonist) for 4 hours | ENCBS177LZS | ENCGM016JFT | ENCLB512WDB |
1 | 3 | Homo sapiens A549 cell line genetically modified (episome) using transient transfection treated with 1 μM CpdA (antagonist) for 4 hours | ENCBS177LZS | ENCGM016JFT | ENCLB233TPV |
1 | 2 | Homo sapiens A549 cell line genetically modified (episome) using transient transfection treated with 1 μM CpdA (antagonist) for 4 hours | ENCBS177LZS | ENCGM016JFT | ENCLB358LPL |
3 | 2 | Homo sapiens A549 cell line genetically modified (episome) using transient transfection treated with 1 μM CpdA (antagonist) for 4 hours | ENCBS164IKW | ENCGM016JFT | ENCLB911HNP |
2 | 4 | Homo sapiens A549 cell line genetically modified (episome) using transient transfection treated with 1 μM CpdA (antagonist) for 4 hours | ENCBS371JSE | ENCGM016JFT | ENCLB247YNF |
3 | 1 | Homo sapiens A549 cell line genetically modified (episome) using transient transfection treated with 1 μM CpdA (antagonist) for 4 hours | ENCBS164IKW | ENCGM016JFT | ENCLB461YXX |
4 | 2 | Homo sapiens A549 cell line genetically modified (episome) using transient transfection treated with 1 μM CpdA (antagonist) for 4 hours | ENCBS563VWN | ENCGM016JFT | ENCLB158ZIC |
4 | 3 | Homo sapiens A549 cell line genetically modified (episome) using transient transfection treated with 1 μM CpdA (antagonist) for 4 hours | ENCBS563VWN | ENCGM016JFT | ENCLB648KGE |
2 | 2 | Homo sapiens A549 cell line genetically modified (episome) using transient transfection treated with 1 μM CpdA (antagonist) for 4 hours | ENCBS371JSE | ENCGM016JFT | ENCLB374DAX |
3 | 3 | Homo sapiens A549 cell line genetically modified (episome) using transient transfection treated with 1 μM CpdA (antagonist) for 4 hours | ENCBS164IKW | ENCGM016JFT | ENCLB366YHT |
4 | 4 | Homo sapiens A549 cell line genetically modified (episome) using transient transfection treated with 1 μM CpdA (antagonist) for 4 hours | ENCBS563VWN | ENCGM016JFT | ENCLB333FIK |
1 | 1 | Homo sapiens A549 cell line genetically modified (episome) using transient transfection treated with 1 μM CpdA (antagonist) for 4 hours | ENCBS177LZS | ENCGM016JFT | ENCLB069LIM |
3 | 4 | Homo sapiens A549 cell line genetically modified (episome) using transient transfection treated with 1 μM CpdA (antagonist) for 4 hours | ENCBS164IKW | ENCGM016JFT | ENCLB266HWW |
4 | 1 | Homo sapiens A549 cell line genetically modified (episome) using transient transfection treated with 1 μM CpdA (antagonist) for 4 hours | ENCBS563VWN | ENCGM016JFT | ENCLB851UDL |